Cardiac xenotransplantation

Area of Science:

• Cardiovascular Medicine
• Transplantation Immunology
• Biotechnology

Background:

• Heart failure presents a significant medical and public health challenge.
• Current treatments include medical therapy and mechanical devices, but heart transplantation remains the only definitive solution.
• The critical shortage of human donor organs severely limits heart transplantation, while mechanical devices face challenges like blood clotting and infection.

Purpose of the Study:

• To explore cardiac xenotransplantation as a potential biologic solution to the donor organ shortage.
• To review advancements in overcoming immune rejection barriers in xenotransplantation.
• To discuss novel strategies involving genetic engineering and bone marrow chimerism for successful xenogeneic organ transplantation.

Main Methods:

• Utilizing conventional and novel immunosuppressive agents to mitigate immune responses (hyperacute, acute vascular, and cellular rejection).
• Employing molecular biology tools for genetic engineering of donor animals.
• Inducing donor and recipient bone marrow chimerism and tolerance in xenogeneic recipients.

Main Results:

• Significant progress has been made in understanding and addressing the immune response to xenografts.
• Genetic engineering of donor organs shows promise in reducing immunogenicity.
• Bone marrow chimerism and tolerance induction are emerging as key strategies for long-term xenograft survival.

Conclusions:

• Cardiac xenotransplantation is a viable biologic alternative to address the donor organ shortage.
• Overcoming immune rejection is crucial and achievable through advanced immunosuppression and immunomodulation.
• A combination of genetically engineered donors and chimeric recipients represents a promising future strategy for successful xenogeneic cardiac transplantation.